# ADRA2A

## Overview
The ADRA2A gene encodes the adrenoceptor alpha 2A, a subtype of G protein-coupled receptors (GPCRs) that are integral to the modulation of sympathetic nervous system activity. This receptor primarily interacts with catecholamines, such as epinephrine and norepinephrine, and is predominantly expressed in the central nervous system, where it plays a crucial role in regulating sympathetic outflow and mediating the effects of antihypertensive agents (Belfer2004Haplotypebased). Beyond the central nervous system, the adrenoceptor alpha 2A is also active in peripheral tissues, influencing processes such as neurotransmitter release, platelet aggregation, and insulin secretion (Ahles2014Polymorphic). The receptor's function is vital in various physiological contexts, including cardiovascular regulation and metabolic processes, highlighting its significance in both health and disease (Ahles2014Polymorphic).

## Structure


## Function
The ADRA2A gene encodes the alpha-2A adrenergic receptor, a subtype of G protein-coupled receptors that primarily interact with catecholamines such as epinephrine and norepinephrine. This receptor is predominantly found in the central nervous system, where it plays a critical role in modulating sympathetic outflow and mediating the central antihypertensive action of alpha-2 adrenergic receptor agonists like clonidine and moxonidine (Belfer2004Haplotypebased). The receptor is involved in the inhibition of adenylyl cyclase activity, leading to decreased intracellular cAMP levels, which is crucial for regulating various physiological processes (Ahles2014Polymorphic).

In addition to its role in the central nervous system, the alpha-2A adrenergic receptor is active in peripheral tissues, where it regulates neurotransmitter release, platelet aggregation, blood pressure, insulin secretion, and lipolysis (Ahles2014Polymorphic). The receptor's activation in pancreatic beta cells inhibits insulin secretion, which is significant in the context of metabolic regulation and the pathogenesis of type 2 diabetes (Ahles2014Polymorphic). The receptor's function is also linked to the prevention of cardiac hypertrophy and failure due to chronically enhanced catecholamine release (Belfer2004Haplotypebased).

## Clinical Significance
Mutations and alterations in the ADRA2A gene have been implicated in several diseases and conditions. In the context of attention deficit hyperactivity disorder (ADHD), studies have shown that polymorphisms in the ADRA2A gene, such as the DraI polymorphism, are associated with the ADHD combined subtype. These polymorphisms may affect the noradrenergic system, which is crucial for functions like working memory and focused attention (Deupree2006Possible; Park2004Association).

In type 2 diabetes, the ADRA2A gene is linked to impaired insulin secretion. Variants such as rs553668 and c.*427G.A in the 3' UTR are associated with increased fasting glucose levels and diabetes risk. These variants may lead to higher expression of the α2A-adrenoceptor, inhibiting insulin secretion from pancreatic islets (Talmud2011Variants; Ahles2014Polymorphic).

The ADRA2A gene is also associated with Raynaud's syndrome, where increased expression of the receptor in microvascular smooth muscle cells contributes to cold-induced vascular contraction. This suggests a role in regulating vascular tone and blood pressure (Tervi2023The).

Additionally, a mutation in ADRA2A has been identified in atypical familial partial lipodystrophy, affecting fat distribution and leading to increased lipolysis (Garg2016Wholeexome).

## Interactions
ADRA2A, the adrenoceptor alpha 2A, is a G protein-coupled receptor that plays a significant role in various physiological processes through its interactions with other proteins. It is involved in the regulation of neurotransmitter release by interacting with G proteins to inhibit adenylate cyclase activity, thereby reducing cAMP levels. This interaction is crucial for its role in modulating neurotransmission and vascular tone (Corda2022GProtein).

In the context of coronary heart disease (CHD), ADRA2A has been identified as part of a protein complex enriched in genes related to cardiovascular diseases, particularly the cardiac hypertrophy signaling pathway. This complex includes other proteins such as ADRB1 and GRB2, which are involved in overlapping gene sets associated with cardiovascular functions (Jensen2011Protein).

ADRA2A is also implicated in sperm-specific functions, where it stimulates cAMP production and accelerates sperm capacitation. This highlights its role in reproductive physiology, although specific protein interactions in this context are not detailed (Corda2022GProtein). The receptor's involvement in these diverse biological processes underscores its importance in both cardiovascular and reproductive systems.


## References


[1. (Garg2016Wholeexome) Abhimanyu Garg, Shireesha Sankella, Chao Xing, and Anil K. Agarwal. Whole-exome sequencing identifies adra2a mutation in atypical familial partial lipodystrophy. JCI Insight, June 2016. URL: http://dx.doi.org/10.1172/jci.insight.86870, doi:10.1172/jci.insight.86870. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1172/jci.insight.86870)

2. (Tervi2023The) The α2A-adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud’s syndrome. This article has 1 citations.

[3. (Jensen2011Protein) Majken K. Jensen, Tune H. Pers, Piotr Dworzynski, Cynthia J. Girman, Søren Brunak, and Eric B. Rimm. Protein interaction-based genome-wide analysis of incident coronary heart disease. Circulation: Cardiovascular Genetics, 4(5):549–556, October 2011. URL: http://dx.doi.org/10.1161/circgenetics.111.960393, doi:10.1161/circgenetics.111.960393. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1161/circgenetics.111.960393)

[4. (Ahles2014Polymorphic) Andrea Ahles and Stefan Engelhardt. Polymorphic variants of adrenoceptors: pharmacology, physiology, and role in disease. Pharmacological Reviews, 66(3):598–637, June 2014. URL: http://dx.doi.org/10.1124/pr.113.008219, doi:10.1124/pr.113.008219. This article has 94 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.113.008219)

[5. (Corda2022GProtein) Pedro O. Corda, Joana Santiago, and Margarida Fardilha. G-protein coupled receptors in human sperm: an in silico approach to identify potential modulatory targets. Molecules, 27(19):6503, October 2022. URL: http://dx.doi.org/10.3390/molecules27196503, doi:10.3390/molecules27196503. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules27196503)

[6. (Park2004Association) L Park, J T Nigg, I D Waldman, K A Nummy, C Huang-Pollock, M Rappley, and K H Friderici. Association and linkage of α-2a adrenergic receptor gene polymorphisms with childhood adhd. Molecular Psychiatry, 10(6):572–580, November 2004. URL: http://dx.doi.org/10.1038/sj.mp.4001605, doi:10.1038/sj.mp.4001605. This article has 67 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.mp.4001605)

[7. (Belfer2004Haplotypebased) Inna Belfer, Beata Buzas, Heather Hipp, Gabriel Phillips, Julie Taubman, Ilona Lorincz, Catherine Evans, Robert H. Lipsky, Mary-Anne Enoch, Mitchell B. Max, and David Goldman. Haplotype-based analysis of alpha 2a, 2b, and 2c adrenergic receptor genes captures information on common functional loci at each gene. Journal of Human Genetics, 50(1):12–20, December 2004. URL: http://dx.doi.org/10.1007/s10038-004-0211-y, doi:10.1007/s10038-004-0211-y. This article has 36 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10038-004-0211-y)

[8. (Talmud2011Variants) P. J. Talmud, J. A. Cooper, T. Gaunt, M. V. Holmes, S. Shah, J. Palmen, F. Drenos, T. Shah, M. Kumari, M. Kivimaki, J. Whittaker, D. A. Lawlor, I. N. Day, A. D. Hingorani, J. P. Casas, and S. E. Humphries. Variants of adra2a are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies. Diabetologia, 54(7):1710–1719, April 2011. URL: http://dx.doi.org/10.1007/s00125-011-2108-6, doi:10.1007/s00125-011-2108-6. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-011-2108-6)

[9. (Deupree2006Possible) J.D. Deupree, S.D. Smith, C.J. Kratochvil, D. Bohac, C.R. Ellis, J. Polaha, and D.B. Bylund. Possible involvement of alpha‐2a adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(8):877–884, November 2006. URL: http://dx.doi.org/10.1002/ajmg.b.30371, doi:10.1002/ajmg.b.30371. This article has 34 citations.](https://doi.org/10.1002/ajmg.b.30371)